Miracle Mile Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.3M | Buy |
5,678
+75
| +1% | +$30.4K | 0.04% | 241 |
|
2025
Q1 | $2.79M | Buy |
5,603
+93
| +2% | +$46.3K | 0.06% | 186 |
|
2024
Q4 | $2.87M | Sell |
5,510
-405
| -7% | -$211K | 0.06% | 179 |
|
2024
Q3 | $3.66M | Buy |
5,915
+155
| +3% | +$95.9K | 0.08% | 132 |
|
2024
Q2 | $3.19M | Buy |
5,760
+320
| +6% | +$177K | 0.08% | 145 |
|
2024
Q1 | $3.16M | Buy |
5,440
+121
| +2% | +$70.3K | 0.08% | 150 |
|
2023
Q4 | $2.82M | Sell |
5,319
-1,150
| -18% | -$610K | 0.08% | 148 |
|
2023
Q3 | $3.27M | Buy |
6,469
+12
| +0.2% | +$6.07K | 0.1% | 127 |
|
2023
Q2 | $3.37M | Sell |
6,457
-236
| -4% | -$123K | 0.1% | 131 |
|
2023
Q1 | $3.86M | Sell |
6,693
-461
| -6% | -$266K | 0.12% | 129 |
|
2022
Q4 | $3.94M | Buy |
7,154
+2,937
| +70% | +$1.62M | 0.14% | 134 |
|
2022
Q3 | $2.14M | Buy |
4,217
+132
| +3% | +$67K | 0.1% | 141 |
|
2022
Q2 | $2.22M | Sell |
4,085
-633
| -13% | -$344K | 0.1% | 139 |
|
2022
Q1 | $2.79M | Sell |
4,718
-5,208
| -52% | -$3.08M | 0.12% | 132 |
|
2021
Q4 | $6.62M | Buy |
9,926
+305
| +3% | +$204K | 0.26% | 81 |
|
2021
Q3 | $5.5M | Buy |
9,621
+171
| +2% | +$97.7K | 0.26% | 80 |
|
2021
Q2 | $4.77M | Buy |
9,450
+52
| +0.6% | +$26.2K | 0.25% | 77 |
|
2021
Q1 | $4.29M | Buy |
9,398
+5,854
| +165% | +$2.67M | 0.24% | 86 |
|
2020
Q4 | $1.65M | Buy |
3,544
+524
| +17% | +$244K | 0.1% | 163 |
|
2020
Q3 | $1.33M | Buy |
3,020
+1,890
| +167% | +$834K | 0.09% | 160 |
|
2020
Q2 | $409K | Sell |
1,130
-110
| -9% | -$39.8K | 0.03% | 239 |
|
2020
Q1 | $352K | Buy |
1,240
+163
| +15% | +$46.3K | 0.04% | 205 |
|
2019
Q4 | $350K | Buy |
1,077
+33
| +3% | +$10.7K | 0.02% | 226 |
|
2019
Q3 | $304K | Buy |
1,044
+309
| +42% | +$90K | 0.02% | 231 |
|
2019
Q2 | $216K | Hold |
735
| – | – | 0.02% | 244 |
|
2019
Q1 | $201K | Buy |
+735
| New | +$201K | 0.02% | 251 |
|